Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions

Highlights • Neurological diseases increasing in incidence but lack effective treatment. • Complement activation linked to the majority of neurological diseases. • Inhibition of complement generally protective in neurological disease models. • Therapies must balance protective and pathogenic sequela of complement activation. • Complement inhibitors show promise as future candidates for clinical trials.